New Evidence is a third-party publication providing oncology specialists with scientific data from research presented at international and Canadian oncology conferences.A special feature of the journal, the Canadian perspective, gives key opinion leaders a forum to discuss recent developments in oncology and to comment on how these advances may shape Canadian clinical practice. In addition, the investigator commentary sections provide information on key clinical studies from interviews with principal investigators. New Evidence also publishes discussion and expert opinion papers on timely topics of interest to oncologists in Canada.

Our April 2012 issue presents coverage from the 53rd Annual Meeting of the American Society of Hematology (ASH), held in San Diego, California, from December 10–13, 2011. The issue reports findings from key studies using new treatment combinations in patients with chronic lymphocytic leukemia who are unable to tolerate standard regimens. In addition, the results of important studies in relapsed non-Hodgkin lymphoma are discussed. We would like to thank Dr. James Johnston, Dr. Laurie Sehn, and Dr. Tom Kouroukis for their Canadian perspectives. We would also like to thank Dr. Mathias Rummel, Dr. Jennifer Woyach, and Dr. John Byrd for their investigator commentaries.

We invite you to join us to receive the print version of New Evidence. Visit our website often for more reports on current research, downloadable slide presentations on various topics, and future online issues of our journal.